Coya Therapeutics, Inc. (COYA) vs LENZ Therapeutics, Inc. (LENZ)

A side-by-side comparison of Coya Therapeutics, Inc. and LENZ Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — COYA vs LENZ

growth of $100 · dividends reinvested · last 4y
COYA +6.1% (+1.5%/yr)LENZ -47.3% (-14.8%/yr)COYA compounded faster over this window
0200400600Start $1002023202420252026$106$53
COYA LENZ

COYA vs LENZ: by the numbers

  • •LENZ is the larger company ($118M vs $112M market cap).
  • •Both run net losses; COYA's is the smaller (-270.22% vs -586.74% net margin).

Metrics side by side

Valuation

MetricCOYALENZ
P/S ratio13.925.47
P/B ratio0.000.54

Profitability

MetricCOYALENZ
Gross margin99.91%90.14%
Operating margin-255.05%-477.46%
Net margin-270.22%-586.74%
ROE-0.05%-57.47%
ROIC-0.05%-61.84%

Growth (annualized)

MetricCOYALENZ
Total return CAGR (5Y)N/A-35.49%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.